Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64

Iwaszko, Milena; Świerkot, Jerzy; Kolossa, Katarzyna; Jeka, Sławomir; Wiland, Piotr; Bogunia-Kubik, Katarzyna

doi:10.3390/genes9020094

Open AccessAddendum

Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64

¹

Laboratory of Clinical Immunogenetics and Pharmacogenetics, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114 Wrocław, Poland

²

Department of Rheumatology and Internal Medicine, Wrocław Medical University, Borowska 213, 50-556 Wrocław, Poland

³

Clinical Department of Rheumatology and Connective Tissue Diseases, Hospital University Number 2 Jana Biziela, Ujejskiego 75, 85-168 Bydgoszcz, Poland

⁴

Department of Internal, Occupational Diseases, Hypertension and Clinical Oncology, Wrocław Medical University, Borowska 213, 50-556 Wrocław, Poland

^*

Author to whom correspondence should be addressed.

Genes 2018, 9(2), 94; https://doi.org/10.3390/genes9020094

Submission received: 1 February 2018 / Revised: 5 February 2018 / Accepted: 5 February 2018 / Published: 14 February 2018

(This article belongs to the Special Issue DNA Variations in Evolution and Human Diseases)

Download Versions Notes

It has been brought to our attention that the funding of the National Center of Science (Poland) was missing in the acknowledgements section of our published paper [1], and therefore we would like to add this and report the acknowledgements as follows:

Acknowledgments

This work was supported by the National Center of Science (Poland), Grant Nos. 2016/21/B/NZ5/01901 and 2012/05/N/NZ5/02607.

This addendum does not cause any changes to the results or conclusions of the original published paper.

Reference

Iwaszko, M.; Świerkot, J.; Kolossa, K.; Jeka, S.; Wiland, P.; Bogunia-Kubik, K. Influence of NKG2D genetic variants on response to anti-TNF agents in patients with Rheumatoid Arthritis. Genes 2018, 9, 64. [Google Scholar] [CrossRef] [PubMed]

© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Iwaszko, M.; Świerkot, J.; Kolossa, K.; Jeka, S.; Wiland, P.; Bogunia-Kubik, K. Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64. Genes 2018, 9, 94. https://doi.org/10.3390/genes9020094

AMA Style

Iwaszko M, Świerkot J, Kolossa K, Jeka S, Wiland P, Bogunia-Kubik K. Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64. Genes. 2018; 9(2):94. https://doi.org/10.3390/genes9020094

Chicago/Turabian Style

Iwaszko, Milena, Jerzy Świerkot, Katarzyna Kolossa, Sławomir Jeka, Piotr Wiland, and Katarzyna Bogunia-Kubik. 2018. "Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64" Genes 9, no. 2: 94. https://doi.org/10.3390/genes9020094

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64

Acknowledgments

Reference

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI